Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease
7 April 2022 (08:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
Mater Misericordiae University Hospital, Dublin (Ireland)
282 More presentations in this session
Miss C. Chaudron (Montpellier, FR)
Professor P. Jankowski (Warsaw, PL)
Access the full session
The Event
ESC Preventive Cardiology 2022
7 April 2022
08:00 CET
